Reduction of catheter-related bloodstream infections in preterm infants by the use of catheters with the AgION antimicrobial system

Early Human Development

Volumn 89, Issue 1, 2013, Pages 21-25

  Bertini, Giovanna ^a   Elia, Serena ^a   Ceciarini, Federica ^a   Dani, Carlo ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Catheter related bloodstream infection; Preterm infants; Silver; Umbilical venous catheter

Indexed keywords

POLYURETHAN; SILVER;

ANTIMICROBIAL ACTIVITY; ARTICLE; CATHETER INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; MALE; NEWBORN INTENSIVE CARE; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; UMBILICAL VEIN; VEIN CATHETERIZATION;

ANTI-INFECTIVE AGENTS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; DRUG DELIVERY SYSTEMS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; SEPSIS;

EID: 84870838420     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2012.07.003     Document Type: Article

References (32)

1. Gray J.E., Richardson D.K., McCormick M.C., Goldmann D.A. Coagulase negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome. Pediatrics 1995, 95(2):225-230.
2. Fanaroff A.A., Korones S.B., Wright L.L., Verter J., Poland R.L., Bauer C.R., et al. Incidence, presenting features, risk factors, and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J 1998, 17(7):593-598.
3. Sohn A.H., Garrett D.O., Sinkowitz-Cochran R.L., Grohskopf L.A., Levine G.L., Stover B.H., et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J Pediatr 2001, 139(6):821-827.
4. O'Grady N.P., Alexander M., Dellinger E.P., Gerberding J.L., Heard S.O., Maki D.G., et al. Guidelines for the prevention of intravascular catheter-related infections. Pediatrics 2002, 110(5):e51-e74.
5. Garland J.S., Henrickson K., Maki D.G. The 2002 Hospital Infection Control Practices Advisory Committee Centers for Disease Control and Prevention guideline for prevention of intravascular devise-related infection. Pediatrics 2002, 110(5):1009-1013.
6. Guerti K., Ieven M., Mahieu L. Diagnosis of catheter-related bloodstream infection in neonates: a study on the value of differential time to positivity of paired blood cultures. Pediatr Crit Care Med 2007, 8(5):470-475.
7. Lee J.H. Catheter-related bloodstream infections in neonatal intensive care units. Korean J Pediatr 2011, 54(9):363-367.
8. O'Grady N.P., Alexander M., Burns L.A., Dellinger E.P., Garland J., Heard S.O., et al. Guidelines for the prevention of intravascular catheter-related infections http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html.
9. Mack D., Davies A.P., Harris L.G., Rohde H., Horstkotte M.A., Knobloch J.K. Microbial interactions in Staphylococcus epidermidis biofilms. Anal Bioanal Chem 2007, 387(2):399-408.
10. Zhu Y., Weiss E.C., Otto M., Fey P.D., Smeltzer M.S., Somerville G.A. Staphylococcus aureus metabolism in a biofilm: the influence of arginine on polysaccharide intercellular adhesin synthesis, biofilm formation, and pathogenesis. Infect Immun 2007, 75(9):4219-4226.
11. Murga R., Miller J.M., Donlan R.M. Biofilm formation by Gram-negative bacteria on central venous catheter connectors: effect of conditioning films in a laboratory model. J Clin Microbiol 2001, 39(6):2294-2297.
12. Douglas L.J. Candida biofilms and their role in infection. Trends Microbiol 2003, 11(1):30-36.
13. von Eiff C., Peters G., Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002, 2(11):677-685.
14. Donlan R.M. Role of biofilms in antimicrobial resistance. ASAIO J 2000, 46:S47-S52.
15. Farber B.F., Kaplan M.H., Clogston A.G. Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics. J Infect Dis 1990, 161(11):37-40.
16. Garland J.S., Alex C.P., Sevallius J.M., Murphy D.M., Good M.J., Volberding A.M., et al. Cohort study of the pathogenesis and molecular epidemiology of catheter-related bloodstream infection in neonates with peripherally inserted central venous catheters. Infect Control Hosp Epidemiol 2008, 29(3):243-249.
17. Garland J.S., Alex C.P., Henrickson K.J., McAuliffe T.L., Maki D.G. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Pediatrics 2005, 116(2):e198-e205.
18. Filippi L., Pezzati M., Di Amario S., Poggi C., Pecile P. Fusidic acid and heparin lock solution for the prevention of catheter-related bloodstream infections in critically ill neonates: a retrospective study and a prospective, randomized trial. Pediatr Crit Care Med 2007, 8(6):556-562.
19. Maki D.G., Stolz S.M., Wheeler S., Mermel L.A. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997, 127(4):257-266.
20. Darouiche R.O., Raad I.I., Heard S.O., Thornby J.I., Wenker O.C., Gabrielli A., et al. A comparison of two antimicrobial impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999, 340(1):1-8.
21. Khare M.D., Bukhari S.S., Swann A., Spiers P., McLaren I., Myers J. Reduction of catheter-related colonization by the use of silver zeolite-impregnated central vascular catheter in adult critical care. J Infect 2007, 54(2):146-150.
22. Loertzer H., Soukup J., Hamza A., Wicht A., Rettkowski O., Koch E., et al. Use of catheters with the AgION antimicrobial system in kidney transplant recipients to reduce infection risk. Transplant Proc 2006, 38(3):707-710.
23. Manual of clinical microbiology 1980, American Society for Microbiology, Washington DC. 3rd ed. E. Lennette, A. Balows, W. Hausler, H. Shadomy (Eds.).
24. Ehrenkranz R.A., Walsh M.C., Vohr B.R., Jobe A.H., Wright L.L., Fanaroff A.A., et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005, 116(6):1353-1360.
25. Papile L.A., Burstein J., Burstein R., Keffler H. Incidence and evolution of the sub-ependymal intraventricular hemorrhage; a study of infants weighing less than 1500grams. J Pediatr 1978, 92(4):529-534.
26. Bell M.J., Ternberg J.L., Feigin R.D., Keating J.P., Marshall R., Barton L., et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg 1978, 187(1):1-12.
27. Anonymous Multicath expert and AgION technology 26/01/2001, Vygon (UK) Limited.
28. Toltzis P. Antibiotic lock technique to reduce central venous catheter related bacteremia. Pediatr Infect Dis J 2006, 25(5):449-450.
29. Butler-O'Hara M., Buzzard C.J., Reubens L., McDermott M.P., DiGrazio W., D'Angio C.T. A randomized trial comparing long-term and short-term use of umbilical venous catheters in premature infants with birth weights of less than 1251grams. Pediatrics 2006, 118:e25-e35.
30. De Brito C.S., de Brito D.V., Abdallah V.O., Gontijo Filho P.P. Occurrence of bloodstream infection with different types of central vascular catheter in critically neonates. J Infect 2010, 60:128-132.
31. Edwards J.R., Peterson K.D., Andrus M.L., Tolson J.S., Goulding J.S., Dudeck M.A., et al. National Healthcare Safety Network (NHSN) report, data summary for 2006, issued June 2007. Am J Infect Control 2007, 35:290-301.
32. Edwards J.R., Peterson K.D., Andrus M.L., Tolson J.S., Goulding J.S., Dudeck M.A., et al. National Healthcare Safety Network (NHSN) report, data summary for 2006, issued June 2007. Am J Infect Control 2007, 35:290-301.